Antithrombotische Therapie nach peripheren 
arteriellen Gefäßeingriffen

K. Halbritter; G. Bötticher; R.-T. Hoffmann; N. Weiss

doi:10.1055/s-0034-1369843

DMW – Klinischer Fortschritt, Table of Contents

Dtsch Med Wochenschr 2014; 139(14): 680-683
DOI: 10.1055/s-0034-1369843

Angiologie | Commentary

Angiologie, Gefäßchirurgie

Antithrombotische Therapie nach peripheren arteriellen Gefäßeingriffen

Antithrombotic treatment after peripheral arterial surgery

K. Halbritter

¹Universitäts GefäßCentrum und Medizinische Klinik III – Bereich Angiologie

,

G. Bötticher

²Universitäts GefäßCentrum und Klinik für Viszeral-, Thorax- und Gefäßchirurgie

,

R.-T. Hoffmann

³Universitäts GefäßCentrum und Institut und Poliklinik für Radiologische Diagnostik, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden

,

N. Weiss

¹Universitäts GefäßCentrum und Medizinische Klinik III – Bereich Angiologie

› Author Affiliations

Abstract

Schlüsselwörter

periphere arterielle Verschlusskrankheit - Thrombozytenfunktionshemmer - Antikoagulation

Keywords

peripheral arterial disease - platelet inhibition - anticoagulation

Full Text

References

Literatur
1 Abbruzzese TA, Havens J, Belkin M et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 2004; 39: 1178-1185
2 Alonso-Coello P, Bellmunt S, McGorrian C et al. Antithrombotic therapy in peripheral artery disease. Chest 2012; 141: e669S-690S
3 Anonymous. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 2000; 355: 346-351
4 Arfvidsson B, Lundgren F, Drott C et al. Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery. Am J Surg 1990; 159: 556-560
5 Belch JJ, Dormandy J, Biasi GM et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 2010; 52: 825-833, 833 e821-822
6 Dorffler-Melly J, Buller HR, Koopman MM et al. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. . Cochrane Database Syst Rev 2003; CD000536
7 Dorffler-Melly J, Koopman MM, Adam DJ et al. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. . Cochrane Database Syst Rev 2003; CD000535
8 Geraghty AJ, Welch K. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. . Cochrane Database Syst Rev 2011; CD000536
9 Iida O, Yokoi H, Soga Y et al. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study. Circulation 2012; 127: 2307-2315
10 Johnson WC, Williford WO. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J Vasc Surg 2002; 35: 413-421
11 Kasapis C, Gurm HS, Chetcuti SJ et al. Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registry. Circ Cardiovasc Interv 2010; 3: 593-601
12 Kretschmer G, Herbst F, Prager M et al. A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. Arch Surg 1992; 127: 1112-1115
13 Robertson L, Ghouri MA, Kovacs F. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. . Cochrane Database Syst Rev 2012; 8 CD002071
14 Sarac TP, Huber TS, Back MR et al. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg 1998; 28: 446-457
15 Spyropoulos A, Douketis J. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood 2012; 120: 2954-2962
16 Tangelder MJ, Lawson JA, Algra A et al. Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery. J Vasc Surg 1999; 30: 701-709
17 Tendera M, Aboyans V, Bartelink ML et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J 2011; 32: 2851-2906
18 Veith FJ, Gupta SK, Ascer E et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986; 3: 104-114
19 Weiss N, Bergert H. Structured surveillance of patients with peripheral arterial occlusive disease after peripheral vascular interventions. Vasa 2009; 38: 302-315
20 Willigendael EM, Teijink JA, Bartelink ML et al. Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg 2005; 42: 67-74